Dow Jones

42,994.39

-0.76%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
AMEX
Interleukin Genetics, (ILI)
Interleukin Genetics, (ILI) News

Interleukin Genetics (ILI)

Interleukin Genetics,

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:ILI

1 2 3 4 5 6 7 Next >>

Date	Time	Source	Headline	Symbol	Company
12/08/2010	20:07	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:ILI	Interleukin Genetics,
05/08/2010	20:01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	AMEX:ILI	Interleukin Genetics,
05/08/2010	12:49	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:ILI	Interleukin Genetics,
05/08/2010	11:02	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
21/07/2010	20:30	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
25/06/2010	21:06	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
21/06/2010	10:31	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
13/05/2010	20:06	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:ILI	Interleukin Genetics,
05/05/2010	10:02	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	AMEX:ILI	Interleukin Genetics,
30/04/2010	23:09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILI	Interleukin Genetics,
30/04/2010	23:06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:ILI	Interleukin Genetics,
30/04/2010	20:36	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
30/04/2010	17:15	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	AMEX:ILI	Interleukin Genetics,
13/04/2010	21:04	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	AMEX:ILI	Interleukin Genetics,
08/04/2010	20:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILI	Interleukin Genetics,
08/04/2010	20:24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILI	Interleukin Genetics,
05/04/2010	20:35	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	AMEX:ILI	Interleukin Genetics,
01/04/2010	20:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILI	Interleukin Genetics,
25/03/2010	20:13	Edgar (US Regulatory)	Annual Report (10-K)	AMEX:ILI	Interleukin Genetics,
19/03/2010	20:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILI	Interleukin Genetics,
10/03/2010	22:11	Edgar (US Regulatory)	Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)	AMEX:ILI	Interleukin Genetics,
09/03/2010	14:46	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	AMEX:ILI	Interleukin Genetics,
05/03/2010	19:52	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(5) (424B5)	AMEX:ILI	Interleukin Genetics,
03/03/2010	19:04	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
01/03/2010	22:00	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
19/02/2010	22:03	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	AMEX:ILI	Interleukin Genetics,
04/02/2010	12:00	PR Newswire (US)	Interleukin Genetics to Present at the 12th Annual BIO CEO Conference	LSE:ILI
03/02/2010	21:34	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	AMEX:ILI	Interleukin Genetics,
02/02/2010	22:01	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,
25/01/2010	21:17	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILI	Interleukin Genetics,